Can circulating M30 and M65 levels be beneficial markers in the diagnosis and management of patients with complete hydatidiform mole?


İNCEBIYIK A., Vural M., CAMUZCUOĞLU H., TAŞKIN A., Camuzcuoglu A., HİLALİ N. G. , ...Daha Fazla

WIENER KLINISCHE WOCHENSCHRIFT, cilt.128, 2016 (SCI İndekslerine Giren Dergi) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 128
  • Basım Tarihi: 2016
  • Doi Numarası: 10.1007/s00508-015-0735-5
  • Dergi Adı: WIENER KLINISCHE WOCHENSCHRIFT

Özet

The objective of this study is to evaluate the prognostic value of M30 and M65 levels as markers of apoptotic activity and maternal serum oxidative stress in patients with complete hydatidiform mole (CHM).